Today: 21 May 2026
Browse Category

NASDAQ:SSAB 29 October 2025

Fossil‑Free Steel Breakthrough: Vattenfall Builds World’s First Green Dam Gate

Fossil‑Free Steel Breakthrough: Vattenfall Builds World’s First Green Dam Gate

Vattenfall will install the world’s first dam gate made from fossil-free steel at its 603 MW Stornorrfors hydropower station by 2028. The 120-tonne gate, produced by SSAB using hydrogen-based HYBRIT technology, will have a carbon footprint about 200 tons lower than conventional steel. SSAB shares rose after the announcement. EU regulators are considering green procurement rules that could favor this technology.
29 October 2025
···

Stock Market Today

  • Borr Drilling Moves to Main Euronext Oslo Børs Market
    May 20, 2026, 8:34 PM EDT. Borr Drilling (BORR) has received approval to transfer its share listing from Euronext Growth Oslo to the main market of Euronext Oslo Børs. This upgrade reflects Borr Drilling's progress and adherence to higher regulatory and reporting standards required by the main market. The move aims to increase the company's visibility and appeal to a broader base of investors, supporting liquidity and trading activity. This transition marks a significant step for Borr Drilling in aligning with more established Nordic market practices.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop